Dr. Cameron Clokie, who is presently the Chief Executive Officer of Induce Biologics Inc., has been active in the field of regenerative surgery since 1998. In his position at Induce Biologics, he was involved in looking for solutions for musculoskeletal reconstruction. At the University of Toronto he served as the Head of Oral and Maxillofacial Surgery, and later as Professor of Oral and Maxillofacial Surgery until he retired this year.
Crunchbase revealed that Dr. Clokie received his training from McGill University in Montreal, receiving his Bachelor of Science Degree in 1981, Doctor of Dental Surgery in 1985, and the Diploma in Oral and Maxillofacial Surgery in 1990. He is a Fellow of the Royal College of Dentists of Canada, a Fellow of the International College of Dentists, and has a Fellowship in the American College of Oral and Maxillofacial Surgery.
While he was at the University of Toronto, Dr. Clokie developed a procedure where bone tissue can be developed by combining a protein with stem cells. This method of bone regeneration has been used in several patients who have lost tissue due to injuries and tumors.
The protein, known as bone morphogeneticprotein or BMP, was first discovered during the 1950’s. It has been used to stimulate the regrowth of the long bones in limbs, used in surgical procedures to help fuse the spine, and was even used to help prevent bone loss around the teeth of pop singer Dionne Warwick. It is now being used in reconstructive jaw surgery for patients in Canada and is also being used by surgeons in South Africa.
Dr. Clokie hopes that the use of bioimplants will eventually eliminate the need for autogeneous bone grafts. He maintained a busy clinical practice in Toronto that focused on bone regeneration and facial surgery.
Clokie Cameron has had articles published in several medical journals concerning regenerative techniques and has lectured on the national and international level. He has been active in outreach work to educate the general public on this technology.